OSI PHARMACEUTICALS, INC.

Inactive Instrument

OSI Pharmaceuticals, Inc. Stock

Stocks

US6710401034

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

Press Releases: OSI Pharmaceuticals, Inc.

10-06-09	OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals	PR
10-06-08	OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI	PR
10-06-04	OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes	BU
10-06-03	OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period	PR
10-05-17	OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010	PR

More press releases

News in other languages: OSI Pharmaceuticals, Inc.

10-05-17

OSI PHARM : a reçu une offre de rachat du japonais Astellas

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	+0.59%	+2.73%	+1.03%	+28.74%	46.68B
	IQVIA HOLDINGS INC.	+1.30%	+1.58%	+44.15%	+35.50%	44.42B
	REVOLUTION MEDICINES, INC.	+0.95%	-6.02%	+342.72%	+532.41%	41.32B
	BEONE MEDICINES AG	+4.23%	+3.35%	+9.35%	+94.73%	41.58B
	CELLTRION, INC.	+1.11%	+1.45%	+11.52%	+45.96%	30.14B
	MEDPACE HOLDINGS, INC.	+1.94%	+4.84%	+25.19%	+159.21%	17.42B
	ASCENDIS PHARMA A/S	+0.37%	-10.32%	-	-	15.6B
	EUROFINS SCIENTIFIC SE	+2.12%	+8.18%	+24.78%	+41.21%	15.54B
	TEMPUS AI, INC.	+0.24%	+25.43%	-11.57%	-	14.08B
	Average	+1.41%	+3.23%	+55.90%	+133.97%	29.64B
	Weighted average by Cap.	+1.53%	+1.71%	+69.93%	+141.94%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!